OpenEvidence Secures $250 Million Funding Round at $15 Billion Valuation

How OpenEvidence Is Changing Clinical Research Workflows

OpenEvidence, an artificial intelligence-powered search engine designed specifically for medical professionals, has raised $250 million in a new funding round that values the company at $15 billion. This represents a significant increase from its $12 billion valuation reported in January of this year. The investment underscores growing confidence in AI tools tailored to healthcare workflows and clinical decision-making. The funding was led by existing and new institutional investors who see strong potential in the platform’s ability to synthesize medical literature quickly and accurately. OpenEvidence plans to use the capital to expand its research team, enhance its AI models, and deepen integrations with electronic health record systems across major hospital networks.

Unlike general-purpose AI search tools, OpenEvidence is trained exclusively on peer-reviewed medical journals, clinical trial data, and authoritative healthcare databases. This focused training allows it to deliver precise, evidence-based answers to complex clinical questions in seconds, reducing the time physicians spend searching for information during patient consultations. Doctors using the platform report saving an average of 20 minutes per day on literature review, according to internal usage data shared with investors. The tool also includes citation tracking and confidence scoring to help users assess the reliability of retrieved information. By minimizing the risk of hallucination—a common issue with broader AI models—OpenEvidence aims to build trust among clinicians who require high-stakes accuracy in their practice.

What Safeguards Are in Place to Prevent Misuse of the Technology?

To ensure responsible deployment, OpenEvidence has implemented strict access controls, limiting use to verified healthcare professionals and accredited medical institutions. The company prohibits indexing or processing of patient-identifiable data and complies with HIPAA and GDPR standards for data privacy. Regular third-party audits are conducted to validate the model’s outputs against established medical guidelines. In response to concerns about AI systems being exploited for unauthorized access—such as recent incidents involving attempts to breach digital libraries using urlquery.net—OpenEvidence has strengthened its API security protocols and monitoring systems. These measures are designed to prevent malicious actors from exploiting the platform while maintaining usability for legitimate medical research.

How does OpenEvidence differ from other AI search engines like those from OpenAI or Google? OpenEvidence is specifically trained on medical literature and clinical data, unlike general AI models that draw from broad internet sources. This specialization results in higher accuracy and relevance for healthcare-specific queries, reducing the likelihood of misleading or irrelevant responses.

Frequently Asked Questions

Is the platform available to medical students or only practicing physicians? Access is currently restricted to licensed healthcare professionals and affiliated medical institutions, including teaching hospitals and accredited medical schools. Verification of professional credentials is required during the sign-up process.

What measures prevent the AI from generating false medical advice? OpenEvidence uses retrieval-augmented generation techniques, meaning its responses are grounded in verifiable sources from its curated medical database. Each answer includes inline citations and a confidence score, allowing users to trace information back to original studies or guidelines.